Filter News
Area of Research
- (-) Fusion and Fission (3)
- (-) Materials for Computing (2)
- Advanced Manufacturing (2)
- Biology and Environment (3)
- Clean Energy (14)
- Computer Science (1)
- Isotope Development and Production (1)
- Isotopes (26)
- Materials (18)
- National Security (19)
- Neutron Science (5)
- Nuclear Science and Technology (9)
- Quantum information Science (2)
- Supercomputing (12)
News Topics
- (-) Fossil Energy (1)
- (-) Isotopes (2)
- (-) Space Exploration (1)
- 3-D Printing/Advanced Manufacturing (7)
- Advanced Reactors (6)
- Artificial Intelligence (1)
- Bioenergy (2)
- Biology (2)
- Biomedical (3)
- Buildings (1)
- Chemical Sciences (8)
- Climate Change (1)
- Composites (2)
- Computer Science (8)
- Coronavirus (3)
- Critical Materials (1)
- Decarbonization (3)
- Energy Storage (8)
- Environment (3)
- Exascale Computing (1)
- Frontier (1)
- Fusion (22)
- Grid (2)
- High-Performance Computing (2)
- ITER (6)
- Materials (11)
- Materials Science (18)
- Microscopy (5)
- Nanotechnology (8)
- National Security (1)
- Net Zero (1)
- Neutron Science (6)
- Nuclear Energy (26)
- Partnerships (3)
- Physics (1)
- Polymers (6)
- Quantum Computing (1)
- Quantum Science (3)
- Security (2)
- Simulation (4)
- Summit (1)
- Sustainable Energy (9)
- Transportation (7)
Media Contacts
“Three-Dimensional Breast Cancer Spheroids” submitted by radiotherapeutics researcher Debjani Pal is stunning. Brilliant blue dots pop from an electric sphere threaded with bright colors: greens, aqua, hot pink and red.
ORNL and the Tennessee Valley Authority, or TVA, are joining forces to advance decarbonization technologies from discovery through deployment through a new memorandum of understanding, or MOU.
More than 50 current employees and recent retirees from ORNL received Department of Energy Secretary’s Honor Awards from Secretary Jennifer Granholm in January as part of project teams spanning the national laboratory system. The annual awards recognized 21 teams and three individuals for service and contributions to DOE’s mission and to the benefit of the nation.
In experiment after experiment, the synthetic radioisotope actinium-225 has shown promise for targeting and attacking certain types of cancer cells.